Hepatocellular carcinoma
Conditions
Interventions
Tumor capsule group:Hepatectomy
Non-tumor capsule group:Hepatectomy
Sponsors
Shanghai General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged 18-85 year old; (2) Postoperative pathological diagnosis authenticates hepatocellular carcinoma; (3) Cirrhotic patients whose Child-Pugh score is Class A or Class A improved from Class B, or non-cirrhotic patients. (4) Patients who voluntarily participate in the trial and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who receive preoperative TACE or RFA; (2) Patients with ruptured hepatocellular carcinoma; (3) Patients who receive hepatectomy for recurrent hepatocellular carcinoma; (4) Patients who receive preoperative systemic chemotherapy or targeted drug therapy; (5) Death of patients within a month after surgery due to surgical complications; (6) Other improper conditions for enrollment (e.g. missing data, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Demographic or clinical characteristics;Enhanced MRI findings;Pathologic factors;Survival time; | — |
Countries
China
Contacts
Public ContactHongcheng Sun
Shanghai General Hospital
Outcome results
None listed